Trupanion (TRUP)
Market Price (2/9/2026): $33.16 | Market Cap: $1.4 BilSector: Financials | Industry: Life & Health Insurance
Trupanion (TRUP)
Market Price (2/9/2026): $33.16Market Cap: $1.4 BilSector: FinancialsIndustry: Life & Health Insurance
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -16% | Weak multi-year price returns2Y Excs Rtn is -17%, 3Y Excs Rtn is -114% | Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 47x, P/EPrice/Earnings or Price/(Net Income) is 92x |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -25% | Meaningful short interestShort Interest Days-to-CoverDTC = (Short Interest Share Quantity) / (Average Daily Trading Volume). Reflects how many days it would take to cover (close out) the short interest based on average volumes. High DTC can signify an increased risk of a short squeeze. is 12.49, Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 11% | Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.1% |
| Attractive yieldFCF Yield is 5.0% | Key risksTRUP key risks include [1] margin compression due to a significant lag in its ability to price for veterinary inflation, Show more. | |
| Megatrend and thematic driversMegatrends include Pet Economy & Humanization. Themes include Pet Insurance & Healthcare Financing, and Pet Health Data Analytics. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -16% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -25% |
| Attractive yieldFCF Yield is 5.0% |
| Megatrend and thematic driversMegatrends include Pet Economy & Humanization. Themes include Pet Insurance & Healthcare Financing, and Pet Health Data Analytics. |
| Weak multi-year price returns2Y Excs Rtn is -17%, 3Y Excs Rtn is -114% |
| Meaningful short interestShort Interest Days-to-CoverDTC = (Short Interest Share Quantity) / (Average Daily Trading Volume). Reflects how many days it would take to cover (close out) the short interest based on average volumes. High DTC can signify an increased risk of a short squeeze. is 12.49, Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 11% |
| Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 47x, P/EPrice/Earnings or Price/(Net Income) is 92x |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.1% |
| Key risksTRUP key risks include [1] margin compression due to a significant lag in its ability to price for veterinary inflation, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Trupanion (TRUP) stock has lost about 15% since 10/31/2025 because of the following key factors:
1. Analyst Downgrades and Price Target Reductions
Trupanion experienced several analyst downgrades and price target cuts during this period, reflecting a more cautious outlook on the company's prospects. Weiss Ratings downgraded Trupanion from a "hold (c-)" to a "sell (d+)" rating in early November 2025. Similarly, Stifel Nicolaus lowered its price target from $45.00 to $42.00, maintaining a "hold" rating in November 2025, a sentiment echoed by Piper Sandler, which reduced its target from $67.00 to $60.00 in December 2025. Wall Street Zen also moved its rating from "buy" to "hold" in December 2025. These revisions collectively contributed to negative investor sentiment and put downward pressure on the stock price.
2. Valuation Concerns and Pressure from Consumer Price Sensitivity
The stock faced ongoing scrutiny regarding its high valuation multiples, particularly its elevated P/E ratio, which analysts questioned given its growth trajectory. Trupanion's P/E ratio was noted at 87.2x, with some analyses even indicating a P/E ratio of 2162 and an EV to EBITDA of 119.55, suggesting a significant valuation premium compared to its earnings growth and industry peers. Compounding these valuation concerns was consumer research indicating that approximately 70% of pet owners were willing to spend a maximum of $70 monthly on pet insurance, which is below Trupanion's average revenue per user of $82. This discrepancy highlighted potential challenges for sustained growth through price increases without impacting customer acquisition or retention.
Show more
1. Analyst Downgrades and Price Target Reductions
Trupanion experienced several analyst downgrades and price target cuts during this period, reflecting a more cautious outlook on the company's prospects. Weiss Ratings downgraded Trupanion from a "hold (c-)" to a "sell (d+)" rating in early November 2025. Similarly, Stifel Nicolaus lowered its price target from $45.00 to $42.00, maintaining a "hold" rating in November 2025, a sentiment echoed by Piper Sandler, which reduced its target from $67.00 to $60.00 in December 2025. Wall Street Zen also moved its rating from "buy" to "hold" in December 2025. These revisions collectively contributed to negative investor sentiment and put downward pressure on the stock price.
2. Valuation Concerns and Pressure from Consumer Price Sensitivity
The stock faced ongoing scrutiny regarding its high valuation multiples, particularly its elevated P/E ratio, which analysts questioned given its growth trajectory. Trupanion's P/E ratio was noted at 87.2x, with some analyses even indicating a P/E ratio of 2162 and an EV to EBITDA of 119.55, suggesting a significant valuation premium compared to its earnings growth and industry peers. Compounding these valuation concerns was consumer research indicating that approximately 70% of pet owners were willing to spend a maximum of $70 monthly on pet insurance, which is below Trupanion's average revenue per user of $82. This discrepancy highlighted potential challenges for sustained growth through price increases without impacting customer acquisition or retention.
Show more
Stock Movement Drivers
Fundamental Drivers
The -17.1% change in TRUP stock from 10/31/2025 to 2/8/2026 was primarily driven by a -40.6% change in the company's P/E Multiple.| (LTM values as of) | 10312025 | 2082026 | Change |
|---|---|---|---|
| Stock Price ($) | 39.99 | 33.17 | -17.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,360 | 1,400 | 2.9% |
| Net Income Margin (%) | 0.8% | 1.1% | 36.4% |
| P/E Multiple | 155.7 | 92.4 | -40.6% |
| Shares Outstanding (Mil) | 43 | 43 | -0.5% |
| Cumulative Contribution | -17.1% |
Market Drivers
10/31/2025 to 2/8/2026| Return | Correlation | |
|---|---|---|
| TRUP | -17.1% | |
| Market (SPY) | 1.3% | 11.2% |
| Sector (XLF) | 3.6% | 16.8% |
Fundamental Drivers
The -30.0% change in TRUP stock from 7/31/2025 to 2/8/2026 was primarily driven by a -33.5% change in the company's P/S Multiple.| (LTM values as of) | 7312025 | 2082026 | Change |
|---|---|---|---|
| Stock Price ($) | 47.41 | 33.17 | -30.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,322 | 1,400 | 5.9% |
| P/S Multiple | 1.5 | 1.0 | -33.5% |
| Shares Outstanding (Mil) | 43 | 43 | -0.7% |
| Cumulative Contribution | -30.0% |
Market Drivers
7/31/2025 to 2/8/2026| Return | Correlation | |
|---|---|---|
| TRUP | -30.0% | |
| Market (SPY) | 9.6% | 20.9% |
| Sector (XLF) | 3.9% | 25.2% |
Fundamental Drivers
The -30.1% change in TRUP stock from 1/31/2025 to 2/8/2026 was primarily driven by a -36.6% change in the company's P/S Multiple.| (LTM values as of) | 1312025 | 2082026 | Change |
|---|---|---|---|
| Stock Price ($) | 47.44 | 33.17 | -30.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,244 | 1,400 | 12.5% |
| P/S Multiple | 1.6 | 1.0 | -36.6% |
| Shares Outstanding (Mil) | 42 | 43 | -2.0% |
| Cumulative Contribution | -30.1% |
Market Drivers
1/31/2025 to 2/8/2026| Return | Correlation | |
|---|---|---|
| TRUP | -30.1% | |
| Market (SPY) | 15.8% | 46.2% |
| Sector (XLF) | 6.5% | 44.9% |
Fundamental Drivers
The -43.8% change in TRUP stock from 1/31/2023 to 2/8/2026 was primarily driven by a -63.8% change in the company's P/S Multiple.| (LTM values as of) | 1312023 | 2082026 | Change |
|---|---|---|---|
| Stock Price ($) | 59.02 | 33.17 | -43.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 854 | 1,400 | 64.0% |
| P/S Multiple | 2.8 | 1.0 | -63.8% |
| Shares Outstanding (Mil) | 41 | 43 | -5.3% |
| Cumulative Contribution | -43.8% |
Market Drivers
1/31/2023 to 2/8/2026| Return | Correlation | |
|---|---|---|
| TRUP | -43.8% | |
| Market (SPY) | 76.2% | 31.2% |
| Sector (XLF) | 55.2% | 31.2% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| TRUP Return | 10% | -64% | -36% | 58% | -22% | -11% | -72% |
| Peers Return | -11% | -47% | -3% | 30% | 22% | -8% | -33% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -1% | 81% |
Monthly Win Rates [3] | |||||||
| TRUP Win Rate | 50% | 33% | 42% | 42% | 33% | 50% | |
| Peers Win Rate | 50% | 35% | 45% | 45% | 45% | 20% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| TRUP Max Drawdown | -40% | -67% | -59% | -35% | -33% | -16% | |
| Peers Max Drawdown | -33% | -56% | -31% | -31% | -23% | -9% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: LMND, CHWY, WOOF, ZTS, IDXX. See TRUP Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/6/2026 (YTD)
How Low Can It Go
| Event | TRUP | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -87.3% | -25.4% |
| % Gain to Breakeven | 689.7% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -36.4% | -33.9% |
| % Gain to Breakeven | 57.1% | 51.3% |
| Time to Breakeven | 88 days | 148 days |
| 2018 Correction | ||
| % Loss | -54.0% | -19.8% |
| % Gain to Breakeven | 117.6% | 24.7% |
| Time to Breakeven | 274 days | 120 days |
Compare to LMND, CHWY, WOOF, ZTS, IDXX
In The Past
Trupanion's stock fell -87.3% during the 2022 Inflation Shock from a high on 12/7/2021. A -87.3% loss requires a 689.7% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Trupanion (TRUP)
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
AI Analysis | Feedback
It's like **UnitedHealth Group (UNH) for pets**.
It's like **GEICO for pet health insurance**.
AI Analysis | Feedback
- Pet Medical Insurance: Trupanion provides comprehensive pet medical insurance policies that help cover the costs of veterinary care for unexpected accidents and illnesses in cats and dogs.
AI Analysis | Feedback
Trupanion (TRUP) sells primarily to individuals. Its major customers can be categorized as:Trupanion (TRUP) sells primarily to individuals. Its major customers can be categorized as:
- New Pet Owners: Individuals who have recently acquired a new puppy or kitten and are proactively seeking to protect their pet from unexpected veterinary costs early in their pet's life.
- Existing Pet Owners Concerned About Future Costs: Pet owners with mature or aging pets, or those who have previously experienced significant veterinary expenses, who are looking for comprehensive coverage to manage potential future health issues and associated costs.
- Pet Owners Prioritizing Comprehensive & Transparent Coverage: Individuals who are specifically seeking a high-quality, comprehensive pet insurance policy with features like Trupanion's 90% reimbursement rate, no per-incident limits, and direct payment to veterinarians, valuing peace of mind and predictable financial protection over lower-cost, less inclusive alternatives.
AI Analysis | Feedback
```html- Munich Re (Symbol: MURGY)
- SCOR SE (Symbol: SCRYY)
- Berkshire Hathaway Inc. (Symbol: BRK.B)
AI Analysis | Feedback
Darryl Rawlings Founder & Chair of the Board
Darryl Rawlings founded Trupanion, originally known as Vetinsurance, in Canada in 1999. A serial entrepreneur, he previously established and sold the Canadian Cigar Company in 1999. His prior experience also includes working as Director of Sales and Marketing at Telos Engineering and selling encryption technology at Cycomm International. He led Trupanion through its initial public offering (IPO) in 2014 and is a founder and member of the North American Pet Health Insurance Association (NAPHIA).
Margi Tooth President & Chief Executive Officer
Margi Tooth joined Trupanion in 2013 and was appointed Chief Executive Officer in August 2024. Her previous roles at Trupanion include President, Co-President, Chief Revenue Officer, Chief Marketing Officer, and various other marketing positions. Before joining Trupanion, she spent over seven years in brand, customer, and digital marketing with a major pet insurance provider in the UK, European insurance giant Allianz. Tooth grew up on a farm and initially aspired to be a veterinarian.
Fawwad Qureshi Chief Financial Officer
Fawwad Qureshi assumed the role of Chief Financial Officer for Trupanion on September 25, 2023, bringing over 20 years of senior-level financial experience. Most recently, he served as Senior Vice President of Finance and CFO of Brands at Expedia Group, where he managed the profit and loss (P&L) and commercial responsibilities for consumer brands like Expedia, Vrbo, Hotels.com, Orbitz, and Travelocity, totaling over $9 billion. Prior to Expedia, he was the CFO for Nike Global Technology and held various finance roles at Intel. Qureshi holds a Master of Business Administration from Boston University.
Emily Dreyer Chief Revenue Officer
Emily Dreyer became Trupanion's Chief Revenue Officer in June 2025. She has been with Trupanion since January 2013, holding a progression of roles including Senior Vice President of Channels, Vice President of Customer Marketing, Head of Customer Marketing, Senior Marketing Manager, Customer Acquisition Manager, Acquisition Specialist, and Marketing Specialist. In her current position, she is responsible for developing and executing the company's short-to-mid-term growth plans and leads the planning and insights teams.
John Gallagher Chief Operating Officer
John Gallagher was appointed Chief Operating Officer of Trupanion in September 2024. He joined the company in 2016 and has held several leadership roles, including Executive Vice President of Global Support Services, interim head of Global Support Services, General Manager for Canada, and various positions within Trupanion's Contact Center. Before his tenure at Trupanion, Gallagher co-owned Mt Diablo Soap Company and worked at T-Mobile and Time Warner Cable, where he managed call center operations and customer relations.
AI Analysis | Feedback
The key risks to Trupanion's business include:
- Rising Veterinary Inflation and its Impact on Profitability: Trupanion faces ongoing challenges from persistent high inflation in veterinary costs. This pressure on costs can compress profit margins and necessitate further price increases for customers. The company's ability to adjust pricing to maintain its target value proposition is critical, but rapid veterinary inflation can outpace their repricing capabilities, which can take 12 to 18 months. Such price hikes could negatively impact customer retention, especially among price-sensitive pet owners.
- Intense Competition and Customer Acquisition Costs: The pet insurance market is highly competitive, with numerous new entrants, including established insurance providers, making the operating environment more challenging. Trupanion's growth strategy relies heavily on increasing spending to acquire new pets. This approach could lead to higher per-pet acquisition costs and put pressure on short-term profitability if the increased spending does not translate into the expected acceleration in new pet growth. The company's disciplined approach to internal rates of return may also limit its ability to compete with rivals employing more aggressive digital advertising strategies.
- Historical Lack of Consistent Profitability and Regulatory/Compliance Issues: Trupanion has a history of incurring significant cumulative net losses since its inception and has struggled to consistently generate positive operating and net income. While the company has shown some recent improvements, questions remain about the long-term sustainability of its current pricing and growth strategies for achieving consistent profitability. Additionally, Trupanion and its subsidiaries have faced citations and fines in multiple states for violating insurance and fraud laws, including issues related to unlicensed individuals selling policies and improper payments for referrals. These regulatory and compliance issues can pose reputational risks and impact the effectiveness of its "Territory Partner model."
AI Analysis | Feedback
nullAI Analysis | Feedback
Trupanion (TRUP) primarily offers pet medical insurance for cats and dogs. The addressable market sizes for their main product in key regions are as follows:
- United States: The pet insurance market in the United States was valued at approximately USD 5.11 billion in 2024 and is projected to reach USD 25.21 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 19.14% from 2025 to 2033. Other estimates for 2024 market size include USD 4.37 billion and USD 4.99 billion. Gross Written Premiums (GWPs) in the U.S. surpassed $4.7 billion in 2024.
- Canada: The Canadian pet insurance market generated a revenue of USD 453.2 million in 2024 and is expected to reach USD 1,526.4 million by 2033, with a projected CAGR of 14.4% from 2025 to 2033. Gross written premiums are expected to reach C$470 million in 2025, with an anticipated annual growth of 10-13% through 2030.
- Continental Europe and Australia: Trupanion operates in Continental Europe (including Belgium, Czech Republic, Germany, Poland, Slovakia, and Switzerland) and Australia. While a specific monetary market size for these regions was not uniformly available, expanding into the European market is estimated to at least double Trupanion's addressable market, with an annual population of 28 million puppies and kittens.
AI Analysis | Feedback
Trupanion (TRUP) is expected to drive future revenue growth over the next 2-3 years through several key initiatives:
- Growth in Subscription Pets: The company has demonstrated an acceleration in subscription pet growth, with a 45% year-over-year increase in net pet additions in Q3 2025. Management has indicated an increased investment in pet acquisition, focusing on higher lifetime value pets, to fuel future growth.
- Pricing and Average Revenue Per Unit (ARPU) Expansion: Trupanion has utilized pricing adjustments as a component of its revenue growth strategy. In Q2 2025, approximately 11% of subscription growth was attributed to pricing. The average monthly revenue per pet in the subscription business has also shown an increase.
- High Customer Retention: While not a direct growth driver, Trupanion's consistently high monthly retention rates, reported at 98.38% and 98.33% in recent periods, provide a stable and recurring revenue base. This strong retention enhances the impact of new pet acquisitions on overall revenue growth.
- Expansion into New Markets and Partnerships: Trupanion is actively expanding its geographic reach, including increasing contributions from its European operations. A recent strategic partnership with BMO Insurance in Canada is also anticipated to drive further market expansion and revenue growth.
- Launch of New Products or Services: The company is exploring and developing adjacent products and services. For example, a "food initiative" was highlighted by analysts as a potential future growth lever, indicating Trupanion's intent to broaden its offerings beyond traditional pet medical insurance.
AI Analysis | Feedback
Share Repurchases
Trupanion has not engaged in significant share repurchase programs over the last 3-5 years. From April 1, 2025, to June 30, 2025, the company repurchased 0 shares for $0 million.
Share Issuance
- The number of Trupanion's outstanding shares has increased from approximately 37.84 million in 2020 to 42.87 million in 2025.
- Proceeds from the exercise of stock options were $2.29 million in 2021 and $0.71 million in 2022.
- The company issued shares valued at $303,000 in June 2025.
Inbound Investments
- In October 2020, Trupanion completed a Private Investment in Public Equity (PIPE) funding round, raising $200 million.
- Since January 2021, the company received a $192 million equity infusion to support new pet acquisition and market expansion initiatives.
Outbound Investments
- In 2021, Trupanion introduced two new pet insurance products, PHI Direct and Furkin, specifically launched in Canada.
- Trupanion established two new wholly-owned insurance subsidiaries, ZPIC Insurance Company and QPIC Insurance Company, in 2021 to expand its underwriting capabilities in the United States.
- The company is expanding its global footprint, including launching a Trupanion-branded product and engaging with strategic automation partners in Germany in Q3 2024.
Capital Expenditures
- Capital expenditures totaled $18.3 million in 2023, primarily focused on the development of internal-use software for member experience, claims processing, and internal policy management improvements.
- In 2022, capital expenditures amounted to $17.1 million, mainly allocated to the development of internal-use software.
- For the first nine months of 2025, operating cash flow was $60.2 million and free cash flow was $50.0 million.
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 53.72 |
| Mkt Cap | 8.6 |
| Rev LTM | 5,083 |
| Op Inc LTM | 202 |
| FCF LTM | 308 |
| FCF 3Y Avg | 225 |
| CFO LTM | 446 |
| CFO 3Y Avg | 384 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 9.2% |
| Rev Chg 3Y Avg | 8.1% |
| Rev Chg Q | 10.2% |
| QoQ Delta Rev Chg LTM | 2.4% |
| Op Mgn LTM | 6.7% |
| Op Mgn 3Y Avg | 4.9% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | 5.5% |
| CFO/Rev 3Y Avg | 4.2% |
| FCF/Rev LTM | 4.5% |
| FCF/Rev 3Y Avg | 2.6% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 8.6 |
| P/S | 3.5 |
| P/EBIT | 39.4 |
| P/E | 35.8 |
| P/CFO | 17.6 |
| Total Yield | 1.4% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 2.4% |
| D/E | 0.1 |
| Net D/E | 0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -8.7% |
| 3M Rtn | -11.5% |
| 6M Rtn | -15.1% |
| 12M Rtn | -22.0% |
| 3Y Rtn | -28.0% |
| 1M Excs Rtn | -9.2% |
| 3M Excs Rtn | -14.9% |
| 6M Excs Rtn | -24.2% |
| 12M Excs Rtn | -38.0% |
| 3Y Excs Rtn | -99.2% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Subscription business | 713 | 597 | 495 | 388 | 321 |
| Other Business | 396 | 309 | 204 | 114 | 63 |
| Total | 1,109 | 905 | 699 | 502 | 384 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Gain (loss) from investment in joint venture | -0 | -0 | -0 | -0 | -0 |
| Other Business | -4 | -3 | -1 | -1 | 0 |
| Subscription business | -36 | -40 | -34 | -4 | -2 |
| Total | -41 | -43 | -35 | -5 | -2 |
Price Behavior
Price Behavior
| Market Price | $33.17 | |
| Market Cap ($ Bil) | 1.4 | |
| First Trading Date | 07/18/2014 | |
| Distance from 52W High | -41.2% | |
| 50 Days | 200 Days | |
| DMA Price | $35.25 | $42.98 |
| DMA Trend | indeterminate | down |
| Distance from DMA | -5.9% | -22.8% |
| 3M | 1YR | |
| Volatility | 33.3% | 53.2% |
| Downside Capture | 98.61 | 141.49 |
| Upside Capture | 3.33 | 86.92 |
| Correlation (SPY) | 10.1% | 46.5% |
TRUP Betas & Captures as of 1/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.55 | 0.54 | 0.64 | 0.71 | 1.30 | 1.47 |
| Up Beta | 0.04 | -1.20 | 0.57 | 0.96 | 1.67 | 1.56 |
| Down Beta | 1.43 | 0.96 | 0.43 | 0.80 | 0.93 | 1.41 |
| Up Capture | 8% | 23% | -1% | -4% | 80% | 150% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 7 | 18 | 24 | 53 | 116 | 358 |
| Down Capture | 409% | 107% | 137% | 123% | 126% | 110% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 13 | 23 | 37 | 72 | 134 | 388 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with TRUP | |
|---|---|---|---|---|
| TRUP | -29.5% | 53.0% | -0.47 | - |
| Sector ETF (XLF) | 6.1% | 19.2% | 0.18 | 45.1% |
| Equity (SPY) | 15.4% | 19.4% | 0.61 | 46.2% |
| Gold (GLD) | 73.9% | 24.8% | 2.19 | -1.9% |
| Commodities (DBC) | 8.9% | 16.6% | 0.34 | 13.9% |
| Real Estate (VNQ) | 4.6% | 16.5% | 0.10 | 33.3% |
| Bitcoin (BTCUSD) | -27.1% | 44.7% | -0.57 | 14.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with TRUP | |
|---|---|---|---|---|
| TRUP | -21.8% | 72.0% | -0.02 | - |
| Sector ETF (XLF) | 15.0% | 18.7% | 0.66 | 35.1% |
| Equity (SPY) | 14.4% | 17.0% | 0.68 | 43.7% |
| Gold (GLD) | 21.4% | 16.9% | 1.03 | 6.5% |
| Commodities (DBC) | 11.5% | 18.9% | 0.49 | 5.5% |
| Real Estate (VNQ) | 5.0% | 18.8% | 0.17 | 38.9% |
| Bitcoin (BTCUSD) | 16.1% | 58.0% | 0.49 | 19.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with TRUP | |
|---|---|---|---|---|
| TRUP | 14.9% | 62.3% | 0.49 | - |
| Sector ETF (XLF) | 14.0% | 22.2% | 0.58 | 30.8% |
| Equity (SPY) | 15.4% | 17.9% | 0.74 | 39.0% |
| Gold (GLD) | 15.7% | 15.5% | 0.84 | 5.5% |
| Commodities (DBC) | 8.0% | 17.6% | 0.37 | 7.6% |
| Real Estate (VNQ) | 6.0% | 20.7% | 0.25 | 30.9% |
| Bitcoin (BTCUSD) | 68.7% | 66.7% | 1.08 | 11.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/6/2025 | -8.3% | -6.4% | -8.7% |
| 2/19/2025 | -25.5% | -28.8% | -22.6% |
| 10/30/2024 | -0.6% | -8.9% | -3.3% |
| 8/8/2024 | 9.3% | 23.6% | 22.4% |
| 5/2/2024 | -16.5% | 4.6% | 18.2% |
| 2/15/2024 | -35.1% | -34.8% | -23.7% |
| 11/2/2023 | 14.3% | -2.6% | 28.6% |
| 8/3/2023 | 6.0% | 2.8% | 0.6% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 6 | 8 | 10 |
| # Negative | 16 | 14 | 12 |
| Median Positive | 10.6% | 15.8% | 18.5% |
| Median Negative | -9.8% | -9.1% | -16.1% |
| Max Positive | 22.7% | 25.8% | 40.7% |
| Max Negative | -35.1% | -38.0% | -39.2% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/01/2025 | 10-Q |
| 12/31/2024 | 02/27/2025 | 10-K |
| 09/30/2024 | 11/01/2024 | 10-Q |
| 06/30/2024 | 08/09/2024 | 10-Q |
| 03/31/2024 | 05/03/2024 | 10-Q |
| 12/31/2023 | 02/27/2024 | 10-K |
| 09/30/2023 | 11/03/2023 | 10-Q |
| 06/30/2023 | 08/04/2023 | 10-Q |
| 03/31/2023 | 05/05/2023 | 10-Q |
| 12/31/2022 | 02/16/2023 | 10-K |
| 09/30/2022 | 11/04/2022 | 10-Q |
| 06/30/2022 | 08/04/2022 | 10-Q |
| 03/31/2022 | 04/29/2022 | 10-Q |
| 12/31/2021 | 02/17/2022 | 10-K |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Gallagher, John R | Chief Operating Officer | Direct | Sell | 12302025 | 37.55 | 430 | 16,146 | 1,212,527 | Form |
| 2 | Tooth, Margaret | CEO | Direct | Sell | 12222025 | 37.88 | 9,605 | 363,850 | 5,693,327 | Form |
| 3 | Gallagher, John R | Chief Operating Officer | Direct | Sell | 12012025 | 34.82 | 6,383 | 222,283 | 1,139,483 | Form |
| 4 | Qureshi, Fawwad | Chief Financial Officer | Direct | Sell | 11262025 | 35.45 | 6,202 | Form | ||
| 5 | Tooth, Margaret | CEO | Direct | Sell | 11262025 | 35.31 | 9,803 | 346,144 | 5,363,554 | Form |
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Life & Health Insurance Resources |
| Insurance Business America |
| A.M. Best |
| National Underwriter |
| Insurance News |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.